In reference to announcement no. 3 of today, board member Niels Tækker Foged has informed BioPorto that he will resign as a member of the board in BioPorto A/S effective from the day of the Extraordinary General Meeting, February 26.
Further information:
Thea Olesen, Adm. CEO
Christina Thomsen, Investor Relations
Telefon 45 29 00 00, mail investor@bioporto.com
June 15, 2026 Announcement no. 13 Grant of Warrants Copenhagen, Denmark, June 15, 2026, (GLOBE NEWSWIRE) – The Board of...
Read MoreJune 9, 2026Announcement no. 12 BioPorto initiates U.S. Adult Validation Study following U.S. Food and Drug Administration (FDA) feedback COPENHAGEN, DENMARK, June 9, 2026 – BioPorto A/S (“BioPorto”...
Read More